Clinical practice guidelines on the evidence‐based use of integrative therapies during and after breast cancer treatment
Top Cited Papers
Open Access
- 24 April 2017
- journal article
- practice guideline
- Published by Wiley in CA: A Cancer Journal for Clinicians
- Vol. 67 (3), 194-232
- https://doi.org/10.3322/caac.21397
Abstract
Answer questions and earn CME/CNE Patients with breast cancer commonly use complementary and integrative therapies as supportive care during cancer treatment and to manage treatment‐related side effects. However, evidence supporting the use of such therapies in the oncology setting is limited. This report provides updated clinical practice guidelines from the Society for Integrative Oncology on the use of integrative therapies for specific clinical indications during and after breast cancer treatment, including anxiety/stress, depression/mood disorders, fatigue, quality of life/physical functioning, chemotherapy‐induced nausea and vomiting, lymphedema, chemotherapy‐induced peripheral neuropathy, pain, and sleep disturbance. Clinical practice guidelines are based on a systematic literature review from 1990 through 2015. Music therapy, meditation, stress management, and yoga are recommended for anxiety/stress reduction. Meditation, relaxation, yoga, massage, and music therapy are recommended for depression/mood disorders. Meditation and yoga are recommended to improve quality of life. Acupressure and acupuncture are recommended for reducing chemotherapy‐induced nausea and vomiting. Acetyl‐L‐carnitine is not recommended to prevent chemotherapy‐induced peripheral neuropathy due to a possibility of harm. No strong evidence supports the use of ingested dietary supplements to manage breast cancer treatment‐related side effects. In summary, there is a growing body of evidence supporting the use of integrative therapies, especially mind‐body therapies, as effective supportive care strategies during breast cancer treatment. Many integrative practices, however, remain understudied, with insufficient evidence to be definitively recommended or avoided. CA Cancer J Clin 2017;67:194–232. © 2017 American Cancer Society.Keywords
This publication has 354 references indexed in Scilit:
- Psychoneuroimmunology-Based Stress Management during Adjuvant Chemotherapy for Early Breast CancerEvidence-Based Complementary and Alternative Medicine, 2013
- Evaluation of Short-Term Use of N-Acetylcysteine as a Strategy for Prevention of Anthracycline-Induced Cardiomyopathy: EPOCH Trial - A Prospective Randomized StudyKorean Circulation Journal, 2013
- Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patientsSupportive Care in Cancer, 2011
- Light treatment prevents fatigue in women undergoing chemotherapy for breast cancerSupportive Care in Cancer, 2011
- Randomized controlled pilot trial of yoga in overweight and obese breast cancer survivors: effects on quality of life and anthropometric measuresSupportive Care in Cancer, 2011
- Reducing vasomotor symptoms with acupuncture in breast cancer patients treated with adjuvant tamoxifen: a randomized controlled trialBreast Cancer Research and Treatment, 2010
- A Randomized Trial of a Cognitive-Behavioral Therapy and Hypnosis Intervention on Positive and Negative Affect During Breast Cancer RadiotherapyJournal of Clinical Psychology, 2009
- Complementary and alternative therapy use before and after breast cancer diagnosis: the Pathways StudyBreast Cancer Research and Treatment, 2009
- The relative importance of specific risk factors for insomnia in women treated for early‐stage breast cancerPsycho‐Oncology, 2007
- Pilot study of acupuncture for the treatment of joint symptoms related to adjuvant aromatase inhibitor therapy in postmenopausal breast cancer patientsJournal of Cancer Survivorship, 2007